Vertex Pharmaceuticals Inc (VRTX)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt VRTX? Forum Prognose Aktiensplit

Finanzdaten der Vertex Pharmaceuticals Inc-Aktie (VRTX)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2025-06-30	2025-03-31	2024-12-31	2024-09-30	2024-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
Revenues	7.02% 2,964.70	2,770.20	2,912.00	2,771.90	2,645.60
Cost Of Revenue	12.26% 407.50	363.00	423.40	392.60	371.90
Gross Profit	6.23% 2,557.20	2,407.20	2,488.60	2,379.30	2,273.70
Operating Expenses	20.88% 1,406.10	1,777.10	1,462.60	1,263.00	5,788.40
Benefits Costs and Expenses	17.56% 1,681.70	2,039.80	1,775.50	1,547.80	6,036.80
Costs And Expenses	15.26% 1,813.60	2,140.10	1,886.00	1,655.60	6,160.30
Operating Income/Loss	82.69% 1,151.10	630.10	1,026.00	1,116.30	-3,514.70
Income/Loss From Continuing Operations Before Tax	75.66% 1,283.00	730.40	1,136.50	1,224.10	-3,391.20
Income Tax Expense/Benefit	197.38% 250.10	84.10	223.50	178.70	202.40
Income/Loss From Continuing Operations After Tax	59.82% 1,032.90	646.30	913.00	1,045.40	-3,593.60
Net Income/Loss	59.82% 1,032.90	646.30	913.00	1,045.40	-3,593.60
Preferred Stock Dividends And Other Adjustments	-	-	-	-	-
Attributable To Noncontrolling Interest	-	-	-	-	-
Basic Average Shares	0.08% 256.70	256.90	-0.20	258.00	258.10
Diluted Average Shares	0.23% 258.90	259.50	-0.20	261.00	258.10
Basic Earnings Per Share	59.52% 4.02	2.52	3.53	4.05	-13.92
Diluted Earnings Per Share	60.24% 3.99	2.49	3.53	4.01	-13.92
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic	-	-	-	-	-

REGN

$642.25

1.47%

ALNY

$434.07

4.82%

ARGX

$826.28

0.95%

INSM

$186.23

1.78%

ONC

$311.86

0.44%